Alcon Inc.
Tažením v grafu vyberte úsek a zobrazí se procentuální změna.Tažením dvěma prsty vyberte úsek a zobrazí se procentuální změna.
Kapitálová struktura
- Tržní kapitalizace
- 26,11 mld. CHF
- Enterprise Value
- 29,28 mld. CHF
- Hotovost
- 1,46 mld. CHF
- Celkový dluh
- 5,3 mld. CHF
- Čistý dluh
- 3,84 mld. CHF
Valuace (TTM)
- P/E
- 50,02×
- P/E (fwd)
- 12,35×
- P/FCF
- 19,93×
- FCF výnos
- 5,02 %
- EV/EBITDA
- 14,77×
- P/S
- —
- P/B
- 1,47×
- Beta
- 0,70
Marže (TTM)
- Hrubá marže
- 57,22 %
- EBITDA marže
- 22,13 %
- Provozní marže
- 14,63 %
- Čistá marže
- 5,92 %
- FCF marže
- 14,63 %
Ziskovost a růst
- ROE (rentabilita kapitálu)
- 2,94 %
- Růst tržeb (YoY)
- 8,70 %
- Růst zisku (YoY)
- —
Dividenda
- Dividendový výnos
- 0,52 %
- Roční dividenda
- 0,28 CHF
- Výplatní poměr
- 27,03 %
- Datum ex-dividendy
- 2026-05-05
52týdenní rozpětí
- Aktuální
- 54,02 CHF
- Pozice v pásmu
- 30 %
- Nad ročním minimem
- +13,01 %
- Pod ročním maximem
- -20,95 %
Cena v kontextu
- Historické maximum
- 54,02 CHF
- Datum maxima
- 23. 9. 2026
- 200denní průměr
- 58,46 CHF
- Odchylka od průměru
- -7,60 %
O společnosti
WebAlcon Inc. researches, develops, manufactures, distributes, and sells eye care products worldwide. The company operates through two segments, Surgical and Vision Care. It offers equipment, instrumentation and diagnostics, intraocular lenses (IOLs), and other implantables; and consumables, including viscoelastics, surgical solutions, incisional instruments, surgical custom packs, and other products for surgical procedures. The company's cataract products include Unity CS, LenSx laser system, Verion reference unit and Verion digital marker, ARGOS biometer, SMARTCATARACT health platform, NGENUITY 3D visualization system, LuxOR surgical ophthalmic microscope, and ORA system for intra-operative measurements; ADI cloud-based platform; and implantable products, including monofocal, Toric, and Presbyopia-Correcting IOLs, as well as delivery systems, such as AutonoMe and UltraSert. In addition, it provides Custom Pak surgical procedure packs vitreoretinal products comprising constellation vision systems, procedure packs, lasers and hand-held microsurgical instruments, Grieshaber, MIVS instruments; scissors, forceps and micro-instruments, medical grade vitreous tamponades, and Hypervit probes; and refractive surgery products, including WaveLight and Contoura Vision used for LASIK refractive procedure. Further, the company offers daily disposable, reusable, and color-enhancing contact lenses; ocular health products, such as dry eye, ocular allergies, glaucoma, and contact lens care, as well as ocular vitamins and redness relievers. The company was formerly known as Alcon Universal S.A. and changed its name to Alcon Inc. in December 2001. Alcon Inc. was founded in 1945 and is headquartered in Geneva, Switzerland.
Vedení společnosti
- Mr. Timothy C. StonesiferSenior VP & CFO
- Mr. Ian BellSenior VP & COO
- Margaret BuckleyChief Accounting Officer
- Dr. Franck Leveiller Ph.D.SVP of Global Research & Development and Chief Scientific Officer
- Mr. Muru MurugappanSenior VP and Chief Information & Transformation Officer
- Mr. Daniel CravensVice President of Investor Relations
- Mr. Royce R. Bedward J.D.Senior VP, General Counsel & Corporate Secretary
- Ms. Kimberly MartinSenior VP and Chief HR & Corporate Communications
- Mr. Leon Sergio Duplan FraustroSenior VP & President of Americas